Patient Leaflet Updated 31-May-2024 | Glenmark Pharmaceuticals Europe Ltd
Rizatriptan 10 mg Orodispersible Tablets
Rizatriptan 10 mg Orodispersible Tablets
rizatriptan
1. What Rizatriptan is and what it is used for
2. What you need to know before you take Rizatriptan
3. How to take Rizatriptan
4. Possible side effects
5. How to store Rizatriptan
6. Contents of the pack and other information
Rizatriptan are used to treat migraine attacks. Do not use them to prevent an attack.
Rizatriptan belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists.
Rizatriptan is used to treat the headache phase of the migraine attack in adults.
Treatment with Rizatriptan:
Reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.
If you are not sure if any of the above apply to you talk to your doctor or pharmacist before taking Rizatriptan.
Talk to your doctor or pharmacist before taking Rizatriptan:
If you take Rizatriptan too often this may result in you getting a chronic headache. In such cases you should contact your doctor as you may have to stop taking Rizatriptan.
Please tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have migraine. You should take Rizatriptan only for a migraine attack. Rizatriptan should not be used to treat headaches that might be caused by other, more serious conditions.
There is no experience with the use of Rizatriptan in children and adolescents under 18 years of age, therefore children and adolescents should not be given Rizatriptan.
There have been no full studies to look at how safe and effective Rizatriptan is amongst patients older than 65 years.
Please tell your doctor or pharmacist if you are taking or have recently taken, or plan to take, any other medicines including medicines obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is because Rizatriptan can affect the way some medicines work. Also other medicines can affect Rizatriptan.
Do not take Rizatriptan:
The above listed medicines when taken with Rizatriptan may increase the risk of side-effects.
You should wait at least 6 hours after taking Rizatriptan before you take ergotamine-type medicines such as ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medicines before taking Rizatriptan.
Ask your doctor for instructions and the risks about taking Rizatriptan if you are taking :
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Rizatriptan can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.
If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Available data on the safety of rizatriptan when used during the first 3 months of pregnancy do not suggest an increased risk of birth defects. It is not known whether rizatriptan is harmful to an unborn baby when taken by a pregnant woman after the first 3 months of pregnancy.
If you are breastfeeding, you may postpone breastfeeding for 12 hours after treatment to avoid exposure in your baby.
You may feel sleepy or dizzy while taking Rizatriptan. If this happens, do not drive or use any tools or machines.
Rizatriptan contains aspartame (E951) Aspartame contains a source of phenylalanine and this may be harmful for people with phenylketonuria.
Always take Rizatriptan exactly as your doctor has told you. You should check with your doctor or your pharmacist if you are not sure.
The recommended dose is 10 mg.
Rizatriptan is an orodispersible tablet that dissolves in the mouth.
If you are currently taking propranolol or have kidney or liver problems you should use the 5-mg dose of Rizatriptan. You should leave at least 2 hours between taking propranolol and Rizatriptan up to a maximum of 2 doses in a 24-hour period.
In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return you can take an additional dose of Rizatriptan. You should always wait at least 2 hours between doses.
If you do not respond to the first dose of Rizatriptan during an attack, you should not take a second dose of Rizatriptan for treatment of the same attack. It is still likely, however, that you will respond to Rizatriptan during the next attack.
Do not take more than 2 doses of Rizatriptan in a 24-hour period (for example, do not take more than two doses of 5 mg or 10 mg orodispersible tablets in a 24-hour period). You should always wait at least 2 hours between doses.
If your condition worsens, seek medical attention.
If you take more Rizatriptan than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you.
Signs of overdose can include dizziness, drowsiness, vomiting, fainting and slow heart rate.
If you have any further questions on the use of this product ask your doctor or pharmacist.
Like all medicines, Rizatriptan can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.
In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or itching) after taking Rizatriptan.
In adult studies, the most common side effects reported were dizziness, sleepiness and tiredness.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via via the Yellow Card Scheme at www.mhra.gov.co.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Keep Rizatriptan out of the sight and reach of children.
Do not use Rizatriptan after the expiry date which is stated on the container after EXP. The expiry date refers to the last day of the month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance of Rizatriptan is rizatriptan.
One 10 mg orodispersible tablet contains 10mg rizatriptan as 14.53 mg of rizatriptan benzoate.
The other ingredients of Rizatriptan tablets are mannitol (E421), microcrystalline cellulose (E460a), crospovidone type A, aspartame (E951), magnesium stearate (E572), Colloidal Silicon Dioxide, peppermint flavor (containing natural flavoring substances and modified food starch E1450).
10 mg orodispersible tablets are white to off white, round, flat, beveled edged uncoated tablets, engraved with ‘468’ on one side and plain on other side
The orodispersible tablets are packed in Aluminium/Aluminium blisters.
10 mg Pack sizes: Packs with 2, 3, 6, 12 or 18 orodispersible tablets.
Not all pack sizes may be marketed.
Rizatriptan is also available as a tablet to be taken with liquids.
This leaflet was last revised in: 05/2024
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950